3658 results for «391»
3658 results
Challenging TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this captivating session that explores challenging TAVI procedures. Witness the management of a patient with pure aortic regurgitation and previous mitral valve replacement, an extremely challenging transfemoral TAVI, the management of bradycardia before TAVI in a patient with MVR and TVR, a case of...
TAV-in-SAV - Part 2
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...
Valve in valve in small degenerative surgical bioprosthesis - LIVE case
09 Feb 2025 – From PCR Tokyo Valves 2025
A 74-year-old female with a permanent pacemaker and preserved LV function presented with a symptomatic degenerative surgical valve (SJ Epic 21) implanted in 2016.
Patient underwent implantation of an Evolut FX 26 mm under general anesthesia with cerebral embolic protection and TEE guidance. A surgical valve fracture...
M-TEER for challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of M-TEER for challenging anatomies. Understand the types of complex anatomies, the associated risks of complications, and learn how to select the appropriate TEER strategy for patients with small left atria, large gaps, and giant left atria. Gain valuable insights to optimize...
TAVI burning issues
09 Feb 2025 – From PCR Tokyo Valves 2025
This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...
Imaging in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...
Valvular interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in valvular interventions in this comprehensive session. Dive into the medical cost analysis of TAVR versus SAVR in Japanese dialysis patients, the long-term outcomes of Myval valve implantation in the pulmonary position, the comparative effectiveness of balloon aortic valvuloplasty techniques,...
Bicuspid and complications
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this comprehensive session exploring the complexities of bicuspid aortic valve disease and the associated complications. Discover tailored sizing techniques for balloon-expandable valves in type 1 bicuspid, navigate the challenges of TAVR in bicuspid aortic valve type 0 with small annulus and coronary compromise, and...
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
Aortic stenosis and coronary artery disease: which should be treated first?
18 Jun 2026
In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.
Author
Transcatheter aortic valve implantation without routine percutaneous coronary intervention: A randomized controlled trial (PRO-TAVI Trial)
29 Mar 2026
Jonathan Curio provides his take on the PRO-TAVI trial presented by Michiel Voskuil at ACC.26 in New Orleans and simultaneously published in The Lancet.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
